뉴스
-
Will Investment Sentiment Return to Bio Amid Tech Adjustment? KM Pharmaceutical and Lemon Healthc...
As the domestic stock market recently enters a breathing spell focused on semiconductors and key Information Technology (IT) stocks, investment sentiment is rapidly returning to the pharmaceutical an...
www.edaily.co.kr · 2026.07.31
-
i-SENS Soars on Earnings, Peptron Rebounds, Cellid Hits Limit-Up[K-Bio Pulse]
South Korean pharmaceutical and biotechnology stocks were mixed Monday, with i-SENS soaring after reporting
www.edaily.co.kr · 2026.07.28
-
[K-Bio Pulse]Biotech Stocks Defy 'Black Tuesday' as MedPacto Soars, Bioinfra Faces Dead...
Despite the "Black Tuesday" selloff on July 28, several biotech stocks bucked the broader market. As the Kosdaq tumbled, Cellid, Bioinfra, and MedPacto all hit the daily upper limit.
www.edaily.co.kr · 2026.07.29
-
HLB Hits Limit-Up on FDA Optimism; Curiosis, Peptron Rebound Sharply [K-Bio Pulse]
On July 15, South Korean pharmaceutical and biotech stocks rallied, led by a broad surge in HLB affiliates , while Curiosis and Peptron posted double-digit gains.Investor sentiment was boosted by rene...
www.edaily.co.kr · 2026.07.16
-
Kosdaq Bio Rally...Alteogen Soars on European Patent Win [K-bio Pulse]
as artificial intelligence (AI) investment expectations combined with strong momentum in healthcare and biotechnology stocks.
www.edaily.co.kr · 2026.07.24
-
Peptron Sinks on Fading Lilly Hopes; Nature Cell, BL Pharmtech Hit Limit-Up [K-Bio Pulse]
On July 9, South Korean pharmaceutical and biotech stocks saw sharply divergent moves, with Nature Cell and BL Pharmtech both hitting the daily upper limit, while Peptron tumbled to the lower limit i...
www.edaily.co.kr · 2026.07.10
-
Mifegyne Approval Hopes Lift Hyundai Pharm and Daehwa [K-Bio Pulse]
South Korea’s pharmaceutical and life sciences sectors broadly declined on July 14.The pharmaceutical Of the 160 stocks in the sector,...
www.edaily.co.kr · 2026.07.15
-
[K-Bio Pulse]Black Friday Hits Korean Biotech
South Korea's pharmaceutical and biotech sector suffered broad-based losses on July 3 in what resembled Stocks that had recently announced major positive developmen...
www.edaily.co.kr · 2026.07.06
-
HLB Jumps on FDA Review Hopes...Seers Rznomics Rally[K-Bio Pulse]
On June 16, South Korea’s pharmaceutical and biotechnology stocks traded largely on company-specific catalysts, including regulatory expectations, business momentum, and shareholder-friendly in...
www.edaily.co.kr · 2026.06.17
-
Biotech Stocks Also Fall Victim to Black Monday…Daewon Pharmaceutical Stands Out [K-Bio Pulse]
South Korean stocks suffered a sharp selloff on Monday as a U.S. driven semiconductor shock and renewed concerns over higher interest rates rattled investor sentiment.Both the benchmark KOSPI and the...
www.edaily.co.kr · 2026.06.09
